DDX34 Antibodies

Santa Cruz Biotechnology delivers a wide array of DDX34 monoclonal antibodies for investigating DDX34's role in cellular processes. DDX34 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). DDX34, a member of the DEAD-box protein family, is involved in RNA metabolism and plays a critical role in the regulation of gene expression. DDX34's function is essential for various cellular processes, including ribosome biogenesis and RNA splicing, making it a significant target for studies related to cellular growth and differentiation. Research focused on DDX34 can provide insights into various diseases, including cancer and neurodegenerative disorders. Scientists worldwide rely on DDX34 monoclonal antibodies to advance their understanding of RNA metabolism and gene regulation. DDX34 monoclonal antibodies enable detailed examination of cellular pathways and molecular mechanisms. Santa Cruz Biotechnology monoclonal antibodies support researchers in making meaningful contributions to scientific knowledge and potential therapeutic developments.